Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 456
Immune Disorders Drugs 193
Cardiovascular Drugs 157
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 111
Clinical Trials 107
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 96
Pharmaceuticals 95
Leukemia Drugs 80
Hematological Drugs 77
Liver and Kidney Disorders Drugs 75
Lymphoma Drugs 62
Diabetes Drugs 57
Dermatological Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Pharmaceutical Intermediates 34
Drug Delivery 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
HIV/AIDS Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Vaccines 8
Transdermal and Transmucosal Drug Delivery 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

2,403 Results (Page 63 of 121)
- Relevance
  Sort by

Skeletal Dysplasia - Global Strategic Business Report

 Report
August 2025
378 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Meglitinide Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

 Report
August 2023
80 Pages
Global

From

€4194EUR$4,750USD£3,635GBP

Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028

 Report
July 2023
373 Pages
Global

From

€2967EUR$3,360USD£2,572GBP

€3708EUR$4,200USD£3,215GBP

Antidepressants Market Report 2025

 Report
March 2025
175 Pages
Global

From

€3965EUR$4,490USD£3,436GBP

Triple Negative Breast Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
November 2023
224 Pages
Global

€4410EUR$4,995USD£3,823GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Rheumatology Therapeutics - Global Strategic Business Report

 Report
August 2025
196 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Antibody Drug Conjugates Market Report 2025-2035

 Report
December 2024
342 Pages
Global

From

€5194EUR$6,088USD£4,350GBP

Anticoagulants - Global Strategic Business Report

 Report
August 2025
196 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030

 Report
March 2025
384 Pages
Global

From

€4371EUR$4,950USD£3,789GBP

Cervical Spondylosis Treatment - Global Strategic Business Report

 Report
August 2025
374 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Andersen-Tawil Syndrome (ATS) - Global Strategic Business Report

 Report
August 2025
276 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Psoriatic Arthritis Treatment - Global Strategic Business Report

 Report
August 2025
452 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Sciatica Treatment - Global Strategic Business Report

 Report
August 2025
380 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Connective Tissue Diseases - Global Strategic Business Report

 Report
August 2025
385 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology and Market Forecast - 2032

 Report
March 2024
257 Pages
Global

From

€6622EUR$7,500USD£5,740GBP

Bipolar Disorder Therapeutics Market Report 2025

 Report
January 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,436GBP

Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides

 Report
August 2025
262 Pages
Global

From

€6176EUR$6,995USD£5,354GBP

Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4194EUR$4,750USD£3,635GBP

Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

 Report
May 2024
343 Pages
Global

From

€4237EUR$4,799USD£3,673GBP

Diverticulitis Disease - Global Strategic Business Report

 Report
August 2025
294 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

2,403 Results (Page 63 of 121)
- 1
- 61
- 62
- 63
- 64
- 65

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.